Medtronic Plc Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Medtronic Plc on September 15, 2025. The filing details a significant capital market transaction involving the issuance of new senior notes and the concurrent redemption of existing debt instruments.
Key Financial Metrics and Transaction Details
- New Debt Issuance: Medtronic, Inc. issued €750 million of 2.950% Senior Notes due 2030 and €750 million of 4.200% Senior Notes due 2045.
- Total Proceeds: The aggregate principal amount of the new offering is €1.5 billion.
- Debt Redemption: Medtronic Global Holdings S.C.A. ("Medtronic Luxco") elected to redeem all €500 million of its outstanding 2.625% Senior Notes due 2025.
- Redemption Terms: The redemption price is 100% of the principal amount plus accrued and unpaid interest, payable on September 29, 2025.
- Guarantees: The new notes are fully and unconditionally guaranteed on a joint and several basis by Medtronic Luxco and Medtronic Plc.
Material Changes and Use of Proceeds
The net proceeds from the new offering are designated to repay Medtronic Luxco's 0.000% Senior Notes due 2025 and the 2.625% Senior Notes due 2025. This transaction represents a refinancing of maturing debt with longer-dated instruments (2030 and 2045 maturities). The financial impact of this offering was already incorporated into the company's fiscal year 2026 adjusted earnings per share guidance, which was reiterated on August 19, 2025.
Guidance, Outlook, and Risks
Management has confirmed that the fiscal year 2026 adjusted earnings per share guidance remains unchanged following this transaction. The redemption of the 2025 notes is conditioned upon the successful completion of the new note issuance on or before the redemption date. If the issuance is not completed, the redemption date may be delayed at Medtronic Luxco's sole discretion.
Investor Verification Checklist
- Verify the final closing of the €1.5 billion note issuance to ensure the condition for the September 29, 2025, redemption is met.
- Confirm the removal of the 0.000% and 2.625% Senior Notes due 2025 from the company's outstanding debt schedule post-redemption.
- Review the Underwriting Agreement (Exhibit 1.1) for specific terms regarding the new 2030 and 2045 notes.
- Monitor the company's liquidity position to ensure sufficient cash flow for the €500 million redemption payment on September 29, 2025.